New method estimates Epstein-Barr virus in blood using standard genome sequencing data

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now identified genetic and non-genetic factors that help the body fight EBV. To do this, they evaluated genome sequencing data, which is actually intended for characterizing the human genome, in a new way.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup